Pharmacy Times® interviewed David Dalton, PharmD, CEO of Univec and advisory board member of IR-Med, on how health technology advancements can progress issues pertaining to health inequities and social determinants of health. Pharmacy Times: What are some of the health tech tools on the market today that are uniquely able to progress efforts in health equity? David Dalton, PharmD: Well, from my perspective it’s AI that [poses] significant advancements that’ve been made with medical devices, along with increasing access to technology, ie, telehealth, is in the forefront. As an example, one of the companies that most recently moved their medical device in a significant area is the company IR-Med, which has a medical device that identifies decubitus ulcers in nursing homes with individuals who are of darker skin. Right now, about 20 to 25% of those conditions are missed, or detected so late that the ulcer has to be treated more extensively, so that technology is wonderful. Second, technology is just the access to telehealth. Telehealth has been able, in my opinion, to give preventive care, access to higher rates of diseases that are diagnosed faster compared to yesterday, and it’s very accessible to the general population, for the […]
Click here to view original web page at www.pharmacytimes.com
